Abstract
OBJECTIVES This study sought to evaluate the ability of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to reduce the r......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
